References

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21834 · 2024 · External reference

The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma

10.1002/hep.32740 · 2023 · External reference

Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy

10.1186/s12943-024-02193-7 · 2024 · External reference

IFNα potentiates Anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment

10.1158/2159-8290.cd-21-1022 · 2022 · External reference

Characteristics of immune response to tumor-associated antigens and immune cell profile in patients with hepatocellular carcinoma

10.1002/hep.30212 · 2019 · External reference

Metabolic plasticity and regulation of T cell exhaustion

10.1111/imm.13575 · 2022 · External reference

Immunotherapies for hepatocellular carcinoma

10.1038/s41571-021-00573-2 · 2022 · External reference

Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: a focus on epithelial-mesenchymal transition

10.1016/j.joim.2021.08.004 · 2021 · External reference

Toll-like receptor 7 activation enhances CD8+ T cell effector functions by promoting cellular glycolysis

10.3389/fimmu.2019.02191 · 2019 · External reference

Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients

10.1111/liv.12847 · 2015 · External reference

Cancer metabolism: looking forward

10.1038/s41568-021-00378-6 · 2021 · External reference

Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM

10.1093/bib/bbad027 · 2023 · External reference

COIMMR: a computational framework to reveal the contribution of herbal ingredients against human cancer via immune microenvironment and metabolic reprogramming

10.1093/bib/bbad346 · 2023 · External reference

Efficacy and safety of Fuzheng Jiedu Xiaoji formula combined with conventional western therapy in advanced HBV-HCC: a single-center, randomized controlled trial

10.1007/s11655-025-3835-8 · 2025 · External reference

Traditional Chinese medicine targeting cancer stem cells as an alternative treatment for hepatocellular carcinoma

10.1016/j.joim.2020.02.002 · 2020 · External reference

Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives

10.1186/s13045-024-01549-2 · 2024 · External reference

GSFM: a genome-scale functional module transformation to represent drug efficacy for in silico drug discovery

10.1016/j.apsb.2024.08.017 · 2025 · External reference

Network medicine-based strategy identifies maprotiline as a repurposable drug by inhibiting PD-L1 expression via targeting SPOP in cancer

10.1002/advs.202410285 · 2025 · External reference

Traditional Chinese medicine enhances the effectiveness of immune checkpoint inhibitors in tumor treatment: a mechanism discussion

10.1016/j.jep.2024.118955 · 2025 · External reference

Molecular and cellular insights into T cell exhaustion

10.1038/nri3862 · 2015 · External reference

Crosstalk between glucose metabolism, lactate production and immune response modulation

10.1016/j.cytogfr.2022.11.001 · 2022 · External reference

Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway

10.1016/j.phymed.2021.153575 · 2021 · External reference

Yangyin Fuzheng Jiedu Prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells

10.1016/j.phymed.2021.153722 · 2021 · External reference

Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib

10.1136/jitc-2019-000317 · 2020 · External reference

Lactate supports Treg function and immune balance via MGAT1 effects on N-glycosylation in the mitochondria

10.1172/jci175897 · 2024 · External reference

Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

10.3350/cmh.2024.0824 · 2025 · External reference

The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine

10.1186/s12943-025-02378-8 · 2025 · External reference

Traditional Chinese medicine and natural products in management of hepatocellular carcinoma: biological mechanisms and therapeutic potential

10.1016/j.phrs.2025.107733 · 2025 · External reference

Identifying antihepatocellular carcinoma compounds in Gansui Banxia decoction using live cell adsorption

10.2147/dddt.s513086 · 2025 · External reference